Skip to content

Clinical trials

Neurodegenerative Diseases trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurodegenerative Diseases Country / region: China Clear all

28 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20111
20121
20161
20183
20214
20225
20232
20244
20252
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting11
Unknown status6
Not yet recruiting5
Completed3
Active, not recruiting1
Enrolling by invitation1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Tianjin Medical University4
Ruijin Hospital3
Fujian Medical University Union Hospital2
Xuanwu Hospital, Beijing2
AstraZeneca1
Beijing Friendship Hospital1
Beijing Tiantan Hospital1
Eisai Limited1
Eli Lilly and Company1
First Affiliated Hospital of Fujian Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurodegenerative Diseases28
Alzheimer Disease13
Dementia8
Cognitive Dysfunction7
Central Nervous System Diseases6
Mental Disorders6
Nervous System Diseases6
Tauopathies6
Brain Diseases5
Parkinson Disease4

Trials

Showing 26 to 28 of 28. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.